Literature DB >> 22172743

A non-randomised trial investigating the cost-effectiveness of Midwifery Group Practice compared with standard maternity care arrangements in one Australian hospital.

Jocelyn Toohill1, Erika Turkstra, Jenny Gamble, Paul A Scuffham.   

Abstract

OBJECTIVE: to compare cost-effectiveness of two models of maternity service delivery: Midwifery Group Practice (MGP) at a birth centre and standard care (SC).
DESIGN: a prospective non-randomised trial.
SETTING: an Australian metropolitan hospital.
METHOD: women at 36 weeks gestation were approached in the birth centre or hospital antenatal clinics between March and December 2008. Of 170 consecutive women who met birth centre eligibility criteria, 70% (n=119) were recruited to the study. Women (MGP n=52 or standard care n=50) were followed through to 6 weeks postpartum. Publically funded care costs were collected from women's diaries, handheld pregnancy health records, medical records and the hospital accounting system. MAIN OUTCOME MEASURES: health-care costs to the hospital and government. ANALYSIS: generalised linear models with covariates of age, nulliparity, private health insurance (yes/no) and household income category.
FINDINGS: women receiving MGP care were less likely to experience induction of labour, required fewer antenatal visits, received more postnatal care, and neonates were less likely to be admitted to special care nursery than those receiving standard care. Statistically significant lower costs were found for women and babies receiving MGP care compared with women receiving standard care during pregnancy, labour and birth and postpartum to 6 weeks. MGP resulted in lower costs for the hospital ($AUD4,696 vs. $AUD5,521 p<0.001) and the government ($AUD4,722 vs. $AUD5,641 p<0.001). When baby costs were excluded MGP care remained statistically significantly cheaper than standard care.
CONCLUSION: for women at low-risk of birth complications, Midwifery Group Practice was cost effective, and women experienced fewer obstetric interventions compared with standard maternity care. The evidence suggests Midwifery Group Practice is safe and economically viable.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22172743     DOI: 10.1016/j.midw.2011.10.012

Source DB:  PubMed          Journal:  Midwifery        ISSN: 0266-6138            Impact factor:   2.372


  6 in total

1.  An interactive decision-making framework (i-DMF) to scale up maternity continuity of carer models.

Authors:  Jocelyn Toohill; Yogesh Chadha; Shelley Nowlan
Journal:  J Res Nurs       Date:  2020-01-17

2.  Implementation barriers and enablers of midwifery group practice for vulnerable women: a qualitative study in a tertiary urban Australian health service.

Authors:  Patricia A Smith; Catherine Kilgour; Deann Rice; Leonie K Callaway; Elizabeth K Martin
Journal:  BMC Health Serv Res       Date:  2022-10-19       Impact factor: 2.908

Review 3.  Costing Alternative Birth Settings for Women at Low Risk of Complications: A Systematic Review.

Authors:  Vanessa Scarf; Christine Catling; Rosalie Viney; Caroline Homer
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

4.  A cost effectiveness analysis of midwife psycho-education for fearful pregnant women - a health system perspective for the antenatal period.

Authors:  J Toohill; E Callander; J Gamble; D K Creedy; J Fenwick
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-11       Impact factor: 3.007

5.  Women's experiences of planning a vaginal birth after caesarean in different models of maternity care in Australia.

Authors:  Hazel Keedle; Lilian Peters; Virginia Schmied; Elaine Burns; Warren Keedle; Hannah Grace Dahlen
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-30       Impact factor: 3.007

6.  The opportunity costs of birth in Australia: Hospital resource savings for a post-COVID-19 era.

Authors:  Emily J Callander; Claudia Bull; Rhona McInnes; Jocelyn Toohill
Journal:  Birth       Date:  2021-02-12       Impact factor: 3.081

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.